help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harigaya, A.
Right arrow Articles by Morikawa, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harigaya, A.
Right arrow Articles by Morikawa, A.
Right arrowPubmed/NCBI databases
*OMIM
*Substance via MeSH
The Journal of Clinical Endocrinology & Metabolism Vol. 82, No. 10 3281-3284
Copyright © 1997 by The Endocrine Society


Original Studies

Relationship between Concentration of Serum Leptin and Fetal Growth

Akira Harigaya, Kanji Nagashima, Yasushi Nako and Akihiro Morikawa

Department of Pediatrics, Gunma University School of Medicine, Maebashi, Gunma, Japan

Address all correspondence and requests for reprints to: Akira Harigaya, M.D., Department of Pediatrics, Gunma University School of Medicine, 3–39-15 Showa-machi, Maebashi, Gunma, 371, Japan. E-mail: ahariga{at}news.sb.gunma-u.ac.jp


    Abstract
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
The serum leptin concentration reflects the amount of adipose tissue in the body. Although fat deposition in the fetus in the third trimester markedly increases, the role of leptin during pregnancy has not been clarified. In the present study, whether or not the serum leptin concentration correlates with growth in utero was investigated, in addition to how leptin levels change in the first few days after birth.

One hundred sixteen Japanese infants were divided into term (n = 91) and preterm groups (n = 25). Term infants were divided into 3 subgroups: birth weight appropriate for gestational age (AGA) (n = 44), birth weight large for gestational age (LGA) (n = 28), and birth weight small for gestational age (SGA) (n = 19). Longitudinal changes in the concentration of serum leptin after birth were examined in 48 infants. The serum leptin concentration was determined by RIA.

No significant difference in leptin levels between cord sera and infants’ sera obtained within the first 6 h of life (n = 28) was observed. Within the first 6 h of life, the concentration of serum leptin in LGA infants (12.8 ± 10.2 ng/mL) and SGA infants (1.6 ± 1.1 ng/mL) was significantly higher and lower, respectively, than that in the AGA infants (4.4 ± 3.0 ng/mL) (P < 0.01). A significant positive correlation was found between the leptin concentration within 6 h of life and birth body weight (r = 0.59, P < 0.01). After birth, the concentration of leptin in LGA and AGA infants significantly decreased to the level in SGA infants within 48 h of delivery (P < 0.05). After 48 h of life, no significant differences in the concentration of leptin were observed among the three groups, and low levels continued to 7 days of age.

These findings indicate that serum level of leptin correlates with fetal body weight gain.


    Introduction
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
LEPTIN IS 16 kDa protein encoded by the ob gene and produced by adipocytes (1, 2). The concentration of serum leptin is high in obese adults and low in lean adults (3, 4). These reports have also demonstrated a strong positive correlation between the serum leptin concentration and amount of body fat. Leptin signals the amount of fat stored in the body to the brain and affects food intake, energy expenditure, and thermogenesis to maintain a constant amount of stored body fat (5, 6). However, the physiological role of leptin in growing children has not been clarified. Two reports have demonstrated that leptin levels correlate highly with body mass index in obese children and rise just before the onset of puberty (7, 8).

Fat deposition in the fetus in the third trimester increases markedly (9). The mechanism of adiposity and physiological roles of leptin in the fetus have yet to be elucidated. In the present study, whether or not the concentration of serum leptin correlates with growth in utero was investigated, in addition to how leptin levels change in the first few days after birth.


    Subjects and Methods
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Subjects

One hundred sixteen Japanese infants were examined. All subjects were born in our hospital between March and December 1996, and the study was limited to infants for whom informed consent could be obtained. Neonates with dysmorphic features, major congenital malformations, intrauterine infections, organic disorders, or chromosomal disorders were excluded. The infants were divided into term (n = 91) and preterm groups (n = 25). Term infants were divided into 3 subgroups: birth weight appropriate for gestational age (AGA) (n = 44), birth weight large for gestational age (LGA) (n = 28), and birth weight small for gestational age (SGA) (n = 19). The body weight of all preterm infants was appropriate for gestational age (AGA). Gestational ages were determined from the last menstrual period of the mother and confirmed by antenatal ultrasonic measurement of the biparietal diameter. Ten mothers who delivered LGA infants had diabetes mellitus (DM) (5 had gestational DM, 4 had noninsulin-dependent DM, 1 had insulin-dependent DM). The Ponderal Index was used for nutritional assessment of the neonate (9). The Ponderal Index was calculated as follows: Ponderal Index = body weight (g)/[body length (cm)]3 x 100. Twenty-five healthy adults (13 males and 12 females), age 31.4 ± 4.7 yr with body mass index 18–25 kg/m2, served as a control.

Blood sampling and examination of serum concentration of leptin and insulin

Twenty-eight samples of cord blood (20 AGA, 6 LGA, and 2 SGA) taken from the 91 term infants were obtained from the umbilical vein immediately after birth. In the 116 infants, venous bloods were obtained within 6 h after birth from antecubital vein. In 48 infants subjected to a longitudinal study of serum leptin levels, venous bloods were obtained from each infant, sometimes at random, at from 2 to 7 days of life, in addition to the sample taken within 6 h after birth. Sera were obtained by centrifugation, immediately frozen, and stored at -20 C until assay. The serum leptin concentration was determined by RIA (Linco Research, St. Louis, MO). The coefficient values of inter- and intraassays were 4.2% and 3.8%, respectively. The detection limit was 0.5 ng/mL. Serum insulin levels were measured using a commercialized enzyme immunoassay kit.

Statistical analysis

All data are expressed as mean ± SD. Differences between groups were tested using the Mann-Whitney test for unrelated samples and the Wilcoxon test for paired samples. Linear regression analysis was used to evaluate correlation. Variance analysis was used to determine significant differences among the groups.


    Results
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
A comparison between the concentration of leptin in cord blood and venous blood obtained within 6 h of birth from the same subjects (n = 28) in three groups is shown in Fig. 1Go. No statistically significant difference in the concentration of leptin was found between these two samples. Thus, for the remainder of this study, the serum concentration of leptin within 6 h of life was assumed to reflect the levels in fetal circulation.



View larger version (25K):
[in this window]
[in a new window]
 
Figure 1. Paired comparison of serum leptin concentration between cord blood and blood obtained within 6 h of life in 28 term infants (20 AGA, 6 LGA, and 2 SGA).

 
The clinical characteristics of each group of term infants are presented in Table 1Go. The placental weight and Ponderal Index of the LGA group were significantly higher than those of the AGA group. Although no statistically significant differences were found among the three groups with respect to serum insulin levels, the LGA group had slightly higher insulin levels.


View this table:
[in this window]
[in a new window]
 
Table 1. Clinical characteristics of the AGA, LGA, and SGA groups

 
The concentrations of serum leptin within 6 h of birth in the term infants (LGA, AGA, and SGA groups) are presented in Fig. 2Go. The serum leptin levels in term AGA infants (4.4 ± 3.0 ng/mL) were significantly lower than those of normal adults in our laboratory (16.9 ± 10.9 ng/mL). The serum leptin concentration in LGA (12.8 ± 10.2 ng/mL) and SGA infants (1.6 ± 1.1 ng/mL) was significantly higher and lower, respectively, than that in AGA infants (P < 0.01).



View larger version (10K):
[in this window]
[in a new window]
 
Figure 2. Concentration of serum leptin in term SGA, AGA, and LGA infants 6 h after birth. Mean levels of serum leptin in term AGA, LGA, and SGA infants were 4.4, 12.8, and 1.6 ng/mL, respectively.

 
A longitudinal study of the concentration of serum leptin in 48 term infants (LGA; n = 12, AGA; n = 27, and SGA; n = 9) is shown in Fig. 3Go. The concentration of leptin in LGA and AGA infants was initially higher than that in the SGA infants and dramatically decreased within 48 h of delivery. These changes in the LGA and AGA infants were statistically significant (P < 0.05). In contrast, the serum concentration of leptin in SGA infants did not change significantly in the first 7 days after birth. After 48 h of life, no significant difference in the serum leptin concentration was found between the three groups, and low levels continued to at least 7 days of age.



View larger version (25K):
[in this window]
[in a new window]
 
Figure 3. Changes in concentration of serum leptin in term SGA, AGA, and LGA infants. Day 0 means within 6 h of birth.

 
Upon analysis of the data of 91 term infants, significant positive correlation was found between the leptin concentration within 6 h of life and birth body weight (r = 0.59, P < 0.01), indicating a progressive increase in the leptin levels with increasing birth body weight (Fig. 4Go, A). In term and preterm AGA infants (n = 69), leptin levels within 6 h of life positively correlated with gestational age (r = 0.50, P < 0.01; Fig. 4Go, B).



View larger version (22K):
[in this window]
[in a new window]
 
Figure 4. A, Comparison of concentration of serum leptin within 6 h after birth with body weight at birth of the 91 infants (44 AGA, 28 LGA, and 19 SGA). B, Comparison of concentration of serum leptin within 6 h after birth with gestational age in the preterm and term AGA infants (n = 69).

 
The body length at birth of 80 term infants had been recorded, and thus the Ponderal Index of these infants could be calculated. Significant positive correlation was found between the leptin levels and Ponderal Index (r = 0.37, P < 0.01)(data not shown).

In term AGA infants, the concentration of serum leptin within 6 h of birth in males (n = 25) and females (n = 19) was 4.0 ± 2.7 and 5.0 ± 3.3 ng/mL, respectively. Therefore, no statistically significant gender effect was observed.

No statistically significant correlation between the concentration of leptin and insulin was observed (data not shown).


    Discussion
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
In the present study, the concentration of serum leptin within 6 h of birth was significantly lower in SGA infants and significantly higher in LGA infants compared with AGA infants. Within 48 h of delivery, the serum leptin levels decreased dramatically in the LGA and AGA groups, and no significant differences in leptin concentration were found among the three groups. In all infants, increases in the serum leptin concentration correlated with increases in body weight at birth. These findings indicate that serum levels of leptin correlate with the fetal body weight gain.

The total amount of body fat is less in SGA infants and greater in LGA infants compared with AGA infants (10). In addition, although body length was determined in 80 term infants in the present study, the Ponderal Index, which is considered useful for assessment of the nutritional state of infants (9), was higher in the LGA group. Thus, we believe that the concentration of serum leptin within 6 h of life closely correlates with the amount of adipose tissue in infants. Linear regression analysis demonstrated there was a significant positive correlation between blood leptin levels and body weight at birth. These results are compatible with the recent reports (11, 12, 13), in which the leptin levels in cord blood correlated positively with birth weight. In a normal pregnancy, the fetal body components grow proportionally, which suggests the presence of fetal feedback and regulatory systems for fetal growth. However, these systems have yet to be elucidated. The findings of the present study indicate that leptin may be involved in one of these systems. A recent study has indicated that a low serum concentration of leptin leads to a reduction in energy expenditure through the increase in neuropeptide Y concentration in the hypothalamus (5). Conversely an increase in the levels of leptin increases energy expenditure (6). Because the energy balance in a growing fetus must be positive, a low concentration of serum leptin is physiologically suitable for fetal growth. In Pima Indians, subjects prone to weight gain initially have lower plasma leptin concentrations than weight- and body composition-matched subjects who maintain a stable weight (14). This data indicates that a relatively low plasma leptin concentration may play a role in the development of obesity in Pima Indians and that the mechanism may be similar to weight gain in the fetus. In addition, to maintain the increase in body mass, a positive feedback system may be operating. In some individuals in the LGA infants, the serum levels of leptin were low and overlapped with those in the SGA infants. Although the reason for this overlapping is unknown, the same phenomenon is found in obese adults. Leptin concentration heterogeneity is known to exist between individuals with the same body mass indes. Some obese patients have extremely high leptin levels, whereas others have levels similar to those seen in lean subjects. One possible explanation for this heterogeneity is that individuals with high plasma levels of leptin are clinically different from individuals with low blood leptin concentrations, resulting in different response to leptin.

In the present study, within 48 h of delivery, the serum leptin concentration in the LGA and AGA infants dramatically decreased to the low levels observed in the SGA infants regardless of birth body weight. One possible explanation for this phenomenon is that the nutritional state reflects the leptin concentration. After delivery, infants can not take full nutrition for several days. In human adults, serum leptin levels rapidly and drastically decrease during fasting in obese and normal subjects (15), suggesting that leptin release is regulated by factors other than changes in body fat mass. An alternative explanation is that the origin of leptin in fetal blood may be placental or maternal blood. A recent abstract reported that leptin messenger RNA was expressed in the placenta (16). However, no reports detailing leptin transference from the mother to the fetus through the placenta have been published.

The effect of gender on leptin concentration has received considerable attention. Although an earlier study did not find a gender effect on leptin levels in human adults (3), such an effect independent of body fat has been detected in another study (17). In the present study, gender had no effect on the concentration of serum leptin in term AGA infants.

Received March 28, 1997.

Accepted July 8, 1997.


    References
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 

  1. Halaas JL, Gajiwala KS, Maffei M, et al. 1995 Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 269:543–546.[Abstract/Free Full Text]
  2. Masuzaki H, Ogawa Y, Isse N, et al. 1995 Human obese gene expression: adipocyte-specific expression and regional differences in the adipose tissue. Diabetes. 44:855–858.[Abstract]
  3. Considine RV, Sinha MK, Heiman ML, et al. 1996 Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 334:292–295.[Abstract/Free Full Text]
  4. Maffei M, Halaas J, Ravussin E, et al. 1995 Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med. 11:1155–1161.
  5. Stephens TW, Basinski M, Bristow PK, et al. 1995 The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 377:530–532.[CrossRef][Medline]
  6. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD. 1997 Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature. 385:165–168.[CrossRef][Medline]
  7. Hassink SG, Sheslow DV, de-Lancey E, Opentanova I, Considine RV, Caro JF. 1996 Serum leptin in children with obesity: relationship to gender and development. Pediatrics. 98:201–203.[Abstract/Free Full Text]
  8. Mantzoros CS, Flier JS, Rogol AD. 1997 A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. Rising leptin levels may signal the onset of puberty. J Clin Endocrinol Metab. 82:1066–1070.[Abstract/Free Full Text]
  9. Pereira GA, Georgieff MK. 1992 Nutritional assessment. In: Polin RA, Fox WW, eds. Fetal and neonatal physiology. Philadelphia: WB Saunders; 277–285.
  10. Enzi G, Zanardo V, Caretta F, Inelmen EM, Rubaltelli F. 1981 Intrauterine growth and adipose tissue development. Am J Clin Nutr. 34:1785–1790.[Abstract/Free Full Text]
  11. Schubring C, Kiess W, Englaro P, et al. 1997 Level of leptin in maternal serum, amniotic fluid, arterial and venous cord blood: relation to neonatal and placental weight. J Clin Endocrinol Metab. 82:1480–1483.[Abstract/Free Full Text]
  12. Matsuda J, Yokota I, Lida M, et al. 1997 Serum leptin concentration in cord blood: relationship to birth weight and gender. J Clin Endocrinol Metab. 82:1642–1644.[Abstract/Free Full Text]
  13. Sivan E, Lin WM, Homko CJ, Reece AR, Boden G. 1997 Leptin is present in human cord blood. Diabetes. 46:917–919.[Abstract]
  14. Ravussin E, Pratley RE, Maffei M, et al. 1997 Relatively low plasma leptin concentrations precede weight gain in Pima Indians. Nature Med. 3:238–240.[CrossRef][Medline]
  15. Boden G, Chen X, Mozzoli M, Ryan I. 1996 Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab. 81:3419–3423.[Abstract]
  16. Hassink SG, Spcar ML, de Lanccy E, et al. 1997 Placental leptin: an important new growth factor in intrauterine and neonatal development? Pediatr Res. 41:232A.
  17. Ma Z, Gingerich RL, Santiago JV, Klein S, Smith CH, Landt M. 1996 Radioimmunoassay of leptin in human plasma. Clin Chem. 42:942–946.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
S. S. Martin, A. Qasim, and M. P. Reilly
Leptin Resistance: A Possible Interface of Inflammation and Metabolism in Obesity-Related Cardiovascular Disease
J. Am. Coll. Cardiol., October 7, 2008; 52(15): 1201 - 1210.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
E. F. M. Wouters, K. H. Groenewegen, M. A. Dentener, and J. H. J. Vernooy
Systemic Inflammation in Chronic Obstructive Pulmonary Disease: The Role of Exacerbations
Proceedings of the ATS, December 1, 2007; 4(8): 626 - 634.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Collinson, S. Moore, M. O'Connell, C. Charalambos, and A. Prentice
Developmental changes in leptin as a measure of energy status in human infants in a natural ecologic setting
Am. J. Clinical Nutrition, February 1, 2005; 81(2): 488 - 494.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Jansson, S. L. Greenwood, B. R. Johansson, T. L. Powell, and T. Jansson
Leptin Stimulates the Activity of the System A Amino Acid Transporter in Human Placental Villous Fragments
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1205 - 1211.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. S. Yajnik, H. G. Lubree, S. S. Rege, S. S. Naik, J. A. Deshpande, S. S. Deshpande, C. V. Joglekar, and J. S. Yudkin
Adiposity and Hyperinsulinemia in Indians Are Present at Birth
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5575 - 5580.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. A. Ehrhardt, A. W. Bell, and Y. R. Boisclair
Spatial and developmental regulation of leptin in fetal sheep
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1628 - R1635.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
T K Hytinantti, M Juntunen, H A Koistinen, V A Koivisto, S-L Karonen, and S Andersson
Postnatal changes in concentrations of free and bound leptin
Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2001; 85(2): F123 - 126.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Christou, J. M. Connors, M. Ziotopoulou, V. Hatzidakis, E. Papathanassoglou, S. A. Ringer, and C. S. Mantzoros
Cord Blood Leptin and Insulin-Like Growth Factor Levels are Independent Predictors of Fetal Growth
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 935 - 938.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
M. C. Henson and V. D. Castracane
Leptin in Pregnancy
Biol Reprod, November 1, 2000; 63(5): 1219 - 1228.
[Abstract] [Full Text]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
P C Ng, C W K Lam, C H Lee, G W K Wong, T F Fok, E Wong, K C Ma, and I H S Chan
Leptin and metabolic hormones in infants of diabetic mothers
Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2000; 83(3): 193F - 197.
[Abstract] [Full Text]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
P C Ng, C W K Lam, C H Lee, G W K Wong, T F Fok, I H S Chan, K C Ma, and E Wong
Leptin and metabolic hormones in preterm newborns
Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2000; 83(3): 198F - 202.
[Abstract] [Full Text]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
T. Hytinantti, H. A Koistinen, V. A Koivisto, S.-L. Karonen, E.-M. Rutanen, S. Andersson;, A. BEREZIN, and M. MELO
Increased leptin concentration in preterm infants of pre-eclamptic mothers
Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2000; 83(1): 13F - 16.
[Abstract] [Full Text]


Home page
Am. J. Clin. Nutr.Home page
A. M Prentice and G. R Goldberg
Energy adaptations in human pregnancy: limits and long-term consequences
Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1226S - 1232.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
D. Chardonnens, P. Cameo, M.L. Aubert, F.P. Pralong, D. Islami, A. Campana, R.C. Gaillard, and P. Bischof
Modulation of human cytotrophoblastic leptin secretion by interleukin-1{alpha} and 17{beta}-oestradiol and its effect on HCG secretion
Mol. Hum. Reprod., November 1, 1999; 5(11): 1077 - 1082.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. C. Henson, V. D. Castracane, J. S. O’Neil, T. Gimpel, K. F. Swan, A. E. Green, and W. Shi
Serum Leptin Concentrations and Expression of Leptin Transcripts in Placental Trophoblast with Advancing Baboon Pregnancy
J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2543 - 2549.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
I. Shimon, X. Yan, D. A. Magoffin, T. C. Friedman, and S. Melmed
Intact Leptin Receptor Is Selectively Expressed in Human Fetal Pituitary and Pituitary Adenomas and Signals Human Fetal Pituitary Growth Hormone Secretion
J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4059 - 4064.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harigaya, A.
Right arrow Articles by Morikawa, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harigaya, A.
Right arrow Articles by Morikawa, A.
Right arrowPubmed/NCBI databases
*OMIM
*Substance via MeSH


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals